510(k) K162227
K162227 is an FDA 510(k) premarket notification submitted by Diagnostica Stago for the device "STA® - Liatest® D-Di". The FDA issued a decision of Substantially Equivalent on Dec 10, 2016. The device falls under product code DAP (Fibrinogen And Fibrin Split Products, Antigen, Antiserum, Control), a Class II device regulated under 21 CFR 864.7320. Diagnostica Stago has 21 other 510(k) clearances on record.
Clearance details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- Dec 10, 2016
- Date Received
- Aug 8, 2016
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device classification
- Device Name
- Fibrinogen And Fibrin Split Products, Antigen, Antiserum, Control
- Device Class
- Class II
- Regulation Number
- 864.7320
- Review Panel
- HE
- Submission Type
- 510(k)
Need the full FDA record for Diagnostica Stago? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.